Three-dimensional ultrasound sits on the fringe of clinical practiceand will likely remain there until real-time 3-D processing becomesa reality, according to Eugene A. Larson, executive vice presidentof ultrasound vendor ATL. "The question is how
Three-dimensional ultrasound sits on the fringe of clinical practiceand will likely remain there until real-time 3-D processing becomesa reality, according to Eugene A. Larson, executive vice presidentof ultrasound vendor ATL.
"The question is how much value (3-D) reconstruction hasversus its time and cost," Larson said. "It is not inthe mainstream of how ultrasound is used as a diagnostic toolright now. Ultrasound reconstruction competes somewhat with MRIand CT. Doctors can go to these other modalities if they wantto do 3-D reconstruction."
ATL has displayed 3-D reconstruction work at trade shows overthe last two years and is investigating ways to increase the clinicalutility of 3-D technology, he said. Prime objectives of the firm's3-D R&D effort are to:
Currently, electronically steered ultrasound transducers canshift their focus in only one plane. These probes maintain a fixedfocal zone in the elevation plane, which lies perpendicular tothe long access of the transducer, Larson said.
Electronic probes create a small circular focal zone at onedepth. At every other depth, focal zones become more egg-shapedas they grow slightly larger in the elevation plane. The challengeis to develop 2-D arrays that can focus in both planes, he said.
"Electronic elevation focus is probably three to fouryears away from a commercial product," Larson said.
Once 2-D transducer arrays are developed to provide image datafor 3-D ultrasound, the amount of information produced will expandtremendously, he said. Rapid processing of this image informationrequires swift transfer of the volumes of data as well as rapidcomputer processing.
"Real-time 3-D will require somewhere around 400 elementsin the transducer," Larson said. "Right now, you can'trun that many cables back to the (processing) system. The costwould be prohibitive."
ATL is tackling this problem by trying to provide high-voltageswitching in the transducer. This multiplexing technology shouldallow one lead to carry information from as many as six transducerelements, he said.
"Until that happens, it (3-D ultrasound) will be all reconstruction,"Larson said.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.